Quality key factors
Factor
Value
Sales Growth (5y)
72.35%
EBIT Growth (5y)
-2.52%
EBIT to Interest (avg)
-13.40
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.30
Sales to Capital Employed (avg)
0.09
Tax Ratio
8.44%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.62
EV to EBIT
-4.58
EV to EBITDA
-5.38
EV to Capital Employed
1.88
EV to Sales
17.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-41.09%
ROE (Latest)
-72.33%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Bullish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Affluent Medical SA
Operating Profit
Highest at EUR -4.97 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (EUR MM)
Pre-Tax Profit
Highest at EUR -6.08 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (EUR MM)
Net Profit
Highest at EUR -5.45 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (EUR MM)
EPS
Highest at EUR -0.14
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (EUR)
Debtors Turnover Ratio
Highest at 1.2%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Affluent Medical SA
Raw Material Cost
Grown by 8,021% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






